文献速递免疫规划卫生政策与健康促进

荷兰COVID-19基础免疫与加强免疫后自发报告的不良事件

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
PubMed 文献 · Vaccine · 2023-05-24

研究描述了2021年1月6日至2022年8月31日荷兰Lareb收到的227,884份COVID-19疫苗接种后自发报告的不良事件(AEFI)。各接种剂次局部和全身AEFI高度相似,多次接种后严重不良事件报告数无明显变化,同源与异源接种序列的AEFI报告模式无差异。

要点

  • 20个月内Lareb共收到227,884份COVID-19疫苗自发AEFI报告。
  • 各接种剂次局部和全身AEFI高度相似,多次接种后严重不良事件报告数无明显变化。
  • 同源与异源基础及加强序列的AEFI报告模式无差异。

核心结论

  • 荷兰同源与异源COVID-19基础及加强免疫序列的自发报告AEFI呈现相似的报告模式。

研究设计与样本

  • 通过Lareb的COVID-19疫苗专用在线报告表收集2021年1月6日至2022年8月31日消费者和医护人员提交的自发报告,共227,884份。

主要发现

  • Lareb在20个月内收到227,884份自发报告。
  • 各接种剂次的局部和全身AEFI高度相似,多次COVID-19疫苗接种后严重不良事件报告数无明显变化。
  • 未观察到各接种序列间报告AEFI模式的差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The rapid roll-out of novel COVID-19 vaccines made near real-time post-marketing safety surveillance essential to identify rare and long-term adverse events following immunization (AEFIs). In light of the ongoing booster vaccination campaigns, it is key to monitor changes in observed safety patterns post-vaccination. The effect of sequential COVID-19 vaccinations, as well as heterologous vaccination sequences, on the observed post-vaccination safety pattern, remains largely unknown. METHODS: The primary objective of this study was to describe the profile of spontaneously reported AEFIs following COVID-19 vaccination in the Netherlands, including the primary and booster series. Reports from consumers and healthcare professionals were collected via a COVID-19 vaccine-tailored online reporting form by the National Pharmacovigilance Centre Lareb (Lareb) between 6 January 2021 and 31 August 2022. The data were used to describe the most frequently reported AEFIs per vaccination moment, the consumer experienced burden per AEFI, and differences in AEFIs reported for homologous and heterologous vaccination sequences. RESULTS: Lareb received 227,884 spontaneous reports over a period of twenty months. Overall, a high degree of similarity in local and systemic AEFIs per vaccination moment was observed, with no apparent change in the number of reports of serious adverse events after multiple COVID-19 vaccinations. No differences in the pattern of reported AEFIs per vaccination sequence was observed. CONCLUSION: Spontaneous reported AEFIs demonstrated a similar reporting pattern for homologous and heterologous primary and booster series of COVID-19 vaccination in the Netherlands.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van der Boor SC, Schmitz-de Vries ETJ, Smits D, et al. Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands. Vaccine. 2023. PMID: 37286408. doi:10.1016/j.vaccine.2023.05.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。